Results 241 to 250 of about 413,940 (274)
Transcriptome Landscape of Cancer‐Associated Fibroblasts in Human PDAC
AP‐1 family members FOS and JUN regulate the malignant phenotype conversion of normal fibroblasts (NFs) to normal‐like cancer‐associated fibroblasts (nCAFs), while transforming growth factor‐β (TGFβ) and interferon‐γ (IFNγ) signals triggers the interconversion between classic myofibroblastic CAFs (myCAFs) and inflammatory CAFs (iCAFs), respectively ...
Mengyu Tao+15 more
wiley +1 more source
Organoid-based precision medicine in pancreatic cancer. [PDF]
Beutel AK+6 more
europepmc +1 more source
High Sugar Induced RCC2 Lactylation Drives Breast Cancer Tumorigenicity Through Upregulating MAD2L1
This study finds that KAT2A mediates the lactylation modification of the non‐histone protein RCC2 at K124, facilitating the recruitment of free SERBP1 and aiding in the formation of the initial SERBP1‐MAD2L1 complex. SERBP1 enhances the stability of MAD2L1 mRNA and promotes cellular proliferation.
Bowen Zheng+11 more
wiley +1 more source
Early onset pancreatic cancer: A review. [PDF]
Luo D, Li Y, Yu X, Ji L, Gong X.
europepmc +1 more source
Pancreatic Cancer: Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer
Tyvin A. Rich+3 more
openalex +1 more source
This study investigates the integrated diagnostic and therapeutic strategy utilizing 89Zr/131I‐labeled tinurilimab for the management of malignant lung nodules, with a particular focus on lung adenocarcinoma (LUAD). CEACAM6, which is highly expressed in most LUAD patients, activates the Src/FAK signaling pathway, thereby promoting cell proliferation ...
Chongyang Chen+8 more
wiley +1 more source
Gemcitabine-induced myositis in a patient with pancreatic cancer. [PDF]
Rubnitz Z+3 more
europepmc +1 more source
Enhancer eccANKRD28‐manipulated MM cells have been demonstrated to facilitate drug resistance and promote MM progression by activating the key transcription factor, POU2F2. POU2F2 interacts with sequence‐specific eccANKRD28 as well as RUNX1 and RUNX2 motifs to form the protein complex, which activates the promoter of oncogenes (IRF4, JUNB, IKZF3, et al.
Binzhen Chen+12 more
wiley +1 more source
Leveraging glycosylation for early detection and therapeutic target discovery in pancreatic cancer. [PDF]
Pienkowski T+5 more
europepmc +1 more source